AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9262798 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric toothbrush (Philips HP550)
Number of subjects: 23
Study 9262798 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush (Butler Gum 111)
Number of subjects: 23
Study 8470423 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant DNA hepatitis B vaccine, 40 micrograms given at months 0, 1, 2 and 6
Number of subjects: 0
Study 8470423 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster injection of 40 micrograms of hepatitis B vaccine in patients vaccinated before transplantation
Number of subjects: 0
Study 8470423 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 3297578 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 8
Study 3297578 — intervention group
Group type: COMPARATOR
Intervention: Multiple injections (MI)
Number of subjects: 8
Study 30141287 — intervention group
Group type: EXPERIMENTAL
Intervention: Plum-blossom needle combined with rehabilitation training
Number of subjects: 61
Study 30141287 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation training
Number of subjects: 61
Study 26942318 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg of propranolol (beta-adrenergic receptor antagonist) administered at encoding
Number of subjects: 0
Study 26942318 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study 26942318 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol administered before memory retrieval
Number of subjects: 0
Study 23995849 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary care
Number of subjects: 47
Study 23995849 — intervention group
Group type: COMPARATOR
Intervention: Dermatological care
Number of subjects: 47
Study 23995849 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary care (patients with psychiatric disorder)
Number of subjects: 47
Study 23995849 — intervention group
Group type: COMPARATOR
Intervention: Dermatological care (patients without psychiatric disorder)
Number of subjects: 47
Study 23770172 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 1790
Study 23770172 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 1790
Study 20092710 — intervention group
Group type: EXPERIMENTAL
Intervention: EN+GH group
Number of subjects: 68
Study 17933497 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 75
Study 17933497 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 75
Study 17933497 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 75
Study 16797593 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole as add-on therapy to levodopa
Number of subjects: 55
Study 16797593 — intervention group
Group type: COMPARATOR
Intervention: Levodopa alone (Control)
Number of subjects: 55
Study 12653895 — intervention group
Group type: EXPERIMENTAL
Intervention: One intra-arterial dose of cisplatin/lipiodol
Number of subjects: 40
Study 12653895 — intervention group
Group type: EXPERIMENTAL
Intervention: Four doses of cisplatin/lipiodol (once every 3 months)
Number of subjects: 40
Study 10502211 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg daily (group A)
Number of subjects: 164
Study 10502211 — intervention group
Group type: COMPARATOR
Intervention: Coumadin plus aspirin (group CA)
Number of subjects: 164
Study 7854528 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesions involving the left posterior supramarginal gyrus and the bordering parietal operculum
Number of subjects: 10
Study 1936506 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 x 100 mg o.d. for 1 day (87 patients)
Number of subjects: 256
Study 1936506 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 x 100 mg b.i.d. for 1 day (83 patients)
Number of subjects: 256
Study 1936506 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 x 100 mg o.d. for 2 days (86 patients)
Number of subjects: 256
Study 7297067 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg vaginal suppository of 9-deoxo-16,16-dimethyl-9-methylene PGE2
Number of subjects: 37
Study 7297067 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg vaginal suppository of 9-deoxo-16,16-dimethyl-9-methylene PGE2
Number of subjects: 37
Study 7297067 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection of 15-methyl PGF2 alpha Tham added at 24 hours
Number of subjects: 37
Study 7297067 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection of 15-methyl PGF2 alpha Tham added at 36 hours
Number of subjects: 37
Study 7297067 — intervention group
Group type: COMPARATOR
Intervention: Vaginal administration of PGE2
Number of subjects: 37
Study 7297067 — intervention group
Group type: COMPARATOR
Intervention: Vaginal administration of 15-methyl PGF2 alpha methyl ester
Number of subjects: 37
Study 7297067 — intervention group
Group type: COMPARATOR
Intervention: Vaginal PGE2
Number of subjects: 37
Study 28426514 — intervention group
Group type: EXPERIMENTAL
Intervention: Hang Pull
Number of subjects: 18
Study 28426514 — intervention group
Group type: COMPARATOR
Intervention: Jump Squat
Number of subjects: 18
Study 28746708 — intervention group
Group type: EXPERIMENTAL
Intervention: Dementia care management (DCM) for 6 months
Number of subjects: 634
Study 28746708 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 634
Study 25540255 — intervention group
Group type: EXPERIMENTAL
Intervention: Bringing in the Bystander™ program
Number of subjects: 2
Study 25540255 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2
Study 23263697 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-chemotherapy interval (PCI)
Number of subjects: 24
Study 23263697 — intervention group
Group type: COMPARATOR
Intervention: Breast cancer survivors (BCS)
Number of subjects: 24
Study 21886189 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral steroid therapy (Prednisolone, 100 mg per day for 5 days)
Number of subjects: 28
Study 21886189 — intervention group
Group type: COMPARATOR
Intervention: No oral steroid (control group)
Number of subjects: 28
Study 20157975 — intervention group
Group type: EXPERIMENTAL
Intervention: Methodological Quality (MQ)
Number of subjects: 137
Study 20157975 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethical Quality (EQ)
Number of subjects: 137
Study 20157975 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between MQ and EQ
Number of subjects: 137
Study 20157975 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed Consent
Number of subjects: 137
Study 20157975 — intervention group
Group type: EXPERIMENTAL
Intervention: Research Ethics Committee Approval
Number of subjects: 137
Study 17804564 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with multiple autoantibodies (3-4 autoantibodies)
Number of subjects: 85
Study 17804564 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with two autoantibodies
Number of subjects: 85
Study 17804564 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (autoantibody-negative)
Number of subjects: 85
Study 15617454 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 40 mg
Number of subjects: 61
Study 15617454 — intervention group
Group type: COMPARATOR
Intervention: Losartan 50 mg
Number of subjects: 61
Study 11578996 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care
Number of subjects: 0
Study 11578996 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 9215439 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational surveys
Number of subjects: 0
Study 9215439 — intervention group
Group type: EXPERIMENTAL
Intervention: Quasi-experimental studies
Number of subjects: 0
Study 9215439 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized controlled experiments
Number of subjects: 0
Study 8423750 — intervention group
Group type: EXPERIMENTAL
Intervention: Downhill walking at 90 m.min‐1
Number of subjects: 10
Study 8423750 — intervention group
Group type: EXPERIMENTAL
Intervention: Downhill walking at 105 m.min‐1
Number of subjects: 10
Study 8423750 — intervention group
Group type: EXPERIMENTAL
Intervention: Downhill walking at -9% and -12% grades
Number of subjects: 10
Study 3663426 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg or 120 mg)
Number of subjects: 10
Study 3663426 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31627908 — intervention group
Group type: EXPERIMENTAL
Intervention: Expanded polytetrafluoroethylene and fluorinated ethylene propylene-covered stents
Number of subjects: 154
Study 31627908 — intervention group
Group type: COMPARATOR
Intervention: Uncovered nitinol stents
Number of subjects: 154
Study 30297544 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 142
Study 30297544 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous catheter drainage
Number of subjects: 142
Study 27679583 — intervention group
Group type: EXPERIMENTAL
Intervention: Absent peripheral pulses (n = 2,218)
Number of subjects: 11120
Study 25677122 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative short-course radiotherapy (PRT) plus total mesorectal excision (TME)
Number of subjects: 242
Study 25677122 — intervention group
Group type: COMPARATOR
Intervention: Total mesorectal excision (TME) alone
Number of subjects: 242
Study 25677122 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative short-course radiotherapy (PRT)
Number of subjects: 242
Study 25677122 — intervention group
Group type: EXPERIMENTAL
Intervention: Age ≤ 75 years at follow-up
Number of subjects: 242
Study 25677122 — intervention group
Group type: EXPERIMENTAL
Intervention: Major LARS
Number of subjects: 242
Study 23592128 — intervention group
Group type: EXPERIMENTAL
Intervention: TUDCA
Number of subjects: 23
Study 23592128 — intervention group
Group type: COMPARATOR
Intervention: UDCA
Number of subjects: 23
Study 21089162 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic X-rays
Number of subjects: 20
Study 18298907 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine
Number of subjects: 26
Study 18298907 — intervention group
Group type: COMPARATOR
Intervention: Normal Saline
Number of subjects: 26
Study 16779748 — intervention group
Group type: EXPERIMENTAL
Intervention: Macrolide therapy
Number of subjects: 0
Study 16779748 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 12818983 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly designed tube with a hemispherical bevel and 2.5 mm outer diameter tube exchanger (TE)
Number of subjects: 0
Study 12818983 — intervention group
Group type: COMPARATOR
Intervention: Conventional polyvinyl chloride tube with a standard bevel
Number of subjects: 0
Study 10221363 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant treatment
Number of subjects: 0
Study 10221363 — intervention group
Group type: COMPARATOR
Intervention: Randomized control trials (RCT), controlled case studies, and epidemiological studies
Number of subjects: 0
Study 8659773 — intervention group
Group type: EXPERIMENTAL
Intervention: High thoracic epidural anesthesia (25 mL lidocaine)
Number of subjects: 32
Study 8659773 — intervention group
Group type: EXPERIMENTAL
Intervention: High thoracic epidural anesthesia (25 mL lidocaine) combined with general anesthesia
Number of subjects: 32
Study 8659773 — intervention group
Group type: COMPARATOR
Intervention: Low thoracic epidural anesthesia (12 mL lidocaine)
Number of subjects: 32
Study 2024848 — intervention group
Group type: EXPERIMENTAL
Intervention: Night sleep study (N)
Number of subjects: 35
Study 2024848 — intervention group
Group type: COMPARATOR
Intervention: Day sleep study (D)
Number of subjects: 35
Study 6661471 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous diazepam
Number of subjects: 2
Study 6661471 — intervention group
Group type: COMPARATOR
Intervention: Blind placebo
Number of subjects: 2
Study 6661471 — intervention group
Group type: COMPARATOR
Intervention: Amyobarbitol
Number of subjects: 2
Study 31571128 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinnarizine 20 mg and Dimenhydrinate 40 mg
Number of subjects: 306
Study 31571128 — intervention group
Group type: COMPARATOR
Intervention: Betahistine Dihydrochloride 16 mg
Number of subjects: 306
Study 30096345 — intervention group
Group type: EXPERIMENTAL
Intervention: Small package size (350 g)
Number of subjects: 205
Study 30096345 — intervention group
Group type: COMPARATOR
Intervention: Large package size (1000 g)
Number of subjects: 205
Study 26951414 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Stress Reduction (MBSR)
Number of subjects: 54
Study 26951414 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Therapy for Insomnia (MBTI)
Number of subjects: 54
Study 26951414 — intervention group
Group type: COMPARATOR
Intervention: self‐monitoring control (SM)
Number of subjects: 54
Study 24411480 — intervention group
Group type: EXPERIMENTAL
Intervention: Mahjong
Number of subjects: 110
Study 24411480 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 110
Study 24411480 — intervention group
Group type: COMPARATOR
Intervention: Simple handicrafts (control)
Number of subjects: 110
Study 21751769 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery treatment group
Number of subjects: 31
Study 21751769 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 31
Study 20484773 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory cue group
Number of subjects: 0
Study 20484773 — intervention group
Group type: COMPARATOR
Intervention: Control group (no auditory cue)
Number of subjects: 0
Study 18515515 — intervention group
Group type: EXPERIMENTAL
Intervention: Foley catheter plus low-dose oxytocin
Number of subjects: 200
Study 18515515 — intervention group
Group type: COMPARATOR
Intervention: Foley catheter alone (control)
Number of subjects: 200
Study 15471616 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS-induced cytokine production during psychosocial stress (Trier social stress test)
Number of subjects: 21
Study 15471616 — intervention group
Group type: COMPARATOR
Intervention: LPS-induced cytokine production
Number of subjects: 21
Study 15471616 — intervention group
Group type: COMPARATOR
Intervention: Fatigue scores and basal LPS-induced cytokine levels
Number of subjects: 21
Study 15471616 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol responses to stress
Number of subjects: 21
Study 15471616 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal levels of stimulated pro-inflammatory IL-6
Number of subjects: 21
Study 12234231 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous labor support by a specially trained nurse
Number of subjects: 6915
Study 12234231 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 6915
Study 9660522 — intervention group
Group type: EXPERIMENTAL
Intervention: Barnidipine (20 mg)
Number of subjects: 106
Study 9660522 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 106
Study 9660522 — intervention group
Group type: COMPARATOR
Intervention: Nitrendipine
Number of subjects: 106
Study 7655932 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing challenge intervention
Number of subjects: 0
Study 7655932 — intervention group
Group type: EXPERIMENTAL
Intervention: Staff training
Number of subjects: 0
Study 2570002 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg acrivastine three times daily
Number of subjects: 83
Study 2570002 — intervention group
Group type: COMPARATOR
Intervention: 60 mg terfenadine twice daily
Number of subjects: 83
Study 4608708 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated monovalent A/Hong Kong vaccine
Number of subjects: 507
Study 4608708 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated monovalent A/England vaccine
Number of subjects: 507
Study 4608708 — intervention group
Group type: COMPARATOR
Intervention: Influenza B vaccine
Number of subjects: 507
Study 29178558 — intervention group
Group type: EXPERIMENTAL
Intervention: Large number training group (10 dilation models, 9 effacement/consistency models)
Number of subjects: 91
Study 29178558 — intervention group
Group type: COMPARATOR
Intervention: Small number training group (4 dilation models, 3 effacement/consistency models)
Number of subjects: 91
Study 26649424 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineural dexmedetomidine (DexP)
Number of subjects: 99
Study 26649424 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexmedetomidine (DexIV)
Number of subjects: 99
Study 26649424 — intervention group
Group type: COMPARATOR
Intervention: Control (no dexmedetomidine)
Number of subjects: 99
Study 24903347 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride
Number of subjects: 4321
Study 24903347 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4321
Study 22959557 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine hydrochloride + epinephrine (Group 1, n = 26)
Number of subjects: 70
Study 22959557 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine hydrochloride + epinephrine (Group 2, n = 35)
Number of subjects: 70
Study 22959557 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% Tramadol (Group 3, n = 12)
Number of subjects: 70
Study 22959557 — intervention group
Group type: COMPARATOR
Intervention: Anxiety scores (correlation analysis)
Number of subjects: 70
Study 20503732 — intervention group
Group type: EXPERIMENTAL
Intervention: KAATSU-walk training (K-walk)
Number of subjects: 19
Study 20503732 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study 18809642 — intervention group
Group type: EXPERIMENTAL
Intervention: Preferred music listening
Number of subjects: 60
Study 18809642 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music intervention)
Number of subjects: 60
Study 16628507 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based rehabilitation program (daily training for three weeks)
Number of subjects: 20
Study 16628507 — intervention group
Group type: COMPARATOR
Intervention: Control group (no computer training)
Number of subjects: 20
Study 12587100 — intervention group
Group type: EXPERIMENTAL
Intervention: Most promising experimental treatments selected at first interim analysis
Number of subjects: 0
Study 12587100 — intervention group
Group type: EXPERIMENTAL
Intervention: Efficient score as a test statistic
Number of subjects: 0
Study 12587100 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial power considerations
Number of subjects: 0
Study 11213099 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa (IFN‐alpha)
Number of subjects: 90
Study 11213099 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic treatment
Number of subjects: 90
Study 9441099 — intervention group
Group type: EXPERIMENTAL
Intervention: STH treatment (streptomycin, thiacetazone, isoniazid)
Number of subjects: 90
Study 7936231 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine (FNR)
Number of subjects: 93
Study 7936231 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 3555382 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma exchange (7 exchange transfusions and one plasmapheresis)
Number of subjects: 20
Study 3555382 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose intravenous gammaglobulins
Number of subjects: 20
Study 2406323 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (standardized Alternaria extract)
Number of subjects: 24
Study 2406323 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 1072558 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam-fentanyl supplemented with Althesin
Number of subjects: 100
Study 1072558 — intervention group
Group type: COMPARATOR
Intervention: Thiemebumal-N2O-O2
Number of subjects: 100
Study 1072558 — intervention group
Group type: COMPARATOR
Intervention: Althesin-N2O-O2
Number of subjects: 100
Study 31138296 — intervention group
Group type: EXPERIMENTAL
Intervention: ChroPreg intervention plus standard care
Number of subjects: 0
Study 31138296 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 0
Study 28951033 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentin-like glass fiber posts (GFPs)
Number of subjects: 91
Study 28951033 — intervention group
Group type: COMPARATOR
Intervention: Rigid titanium posts (TPs)
Number of subjects: 91
Study 28951033 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 91
Study 26375288 — intervention group
Group type: EXPERIMENTAL
Intervention: Active supplementation with selenium and coenzyme Q10
Number of subjects: 437
Study 26375288 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 437
Study 23362293 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholera vaccine
Number of subjects: 66990
Study 23362293 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66990
Study 21480469 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 Gy CNS irradiation
Number of subjects: 486
Study 21480469 — intervention group
Group type: COMPARATOR
Intervention: 18 Gy CNS irradiation
Number of subjects: 486
Study 19461534 — intervention group
Group type: EXPERIMENTAL
Intervention: Active recovery (cycle ergometer, 30‐40 W)
Number of subjects: 13
Study 19461534 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold water immersion (three periods of 5 min at 15 ± 1 degrees C)
Number of subjects: 13
Study 19461534 — intervention group
Group type: COMPARATOR
Intervention: Electromyostimulation (bisymmetric TENS current)
Number of subjects: 13
Study 19461534 — intervention group
Group type: COMPARATOR
Intervention: Passive recovery
Number of subjects: 13
Study 16600647 — intervention group
Group type: EXPERIMENTAL
Intervention: formoterol 12microg via Turbuhaler
Number of subjects: 20
Study 16600647 — intervention group
Group type: EXPERIMENTAL
Intervention: salmeterol 50microg via Diskus
Number of subjects: 20
Study 15035962 — intervention group
Group type: EXPERIMENTAL
Intervention: Gains in balance
Number of subjects: 92
Study 15035962 — intervention group
Group type: EXPERIMENTAL
Intervention: Gains in peak VO2 and lower limb Fugl‐Meyer score
Number of subjects: 92
Study 11473961 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous administration of GnRH agonist during the luteal phase (cL group)
Number of subjects: 319
Study 11473961 — intervention group
Group type: COMPARATOR
Intervention: Long protocol (L group)
Number of subjects: 319
Study 9744590 — intervention group
Group type: EXPERIMENTAL
Intervention: Picolax
Number of subjects: 194